Clinical Trial Update: Efficacy and Safety of Plasma Rich in Growth Factors (PRGF-Endoret) Eye-drops in the Treatment of Neurotrophic Keratitis [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating Plasma Rich in Growth Factors (PRGF-Endoret) eye drops for neurotrophic keratitis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurotrophic Keratitis

Drugs mentioned

• PRGF-Endoret Eye Drops (plasma-rich in growth factors eye drops)

Snippet

Sponsor: Biotechnology Institute IMASD | Conditions: Neurotrophic Keratitis | Phase 4 | Status: WITHDRAWN